The Differences Between Phase 1, Phase 2, and Phase 3 Clinical Trials
For any patient or caregiver who is new to the world of drug development, the different clinical trials can be difficult to comprehend at first.
Read MoreFor any patient or caregiver who is new to the world of drug development, the different clinical trials can be difficult to comprehend at first.
Read MoreBioCanRX provides research assistants, postdocs, graduate students, and technicians with the tools needed to make their science more clinically relevant.
Read MoreBoris Weiss, CEO of Medicare Pharmaceuticals, provides a brief overview of the difficulties to start clinical trials in Canada and his proposed pilot program to alleviate some of those difficulties.
Read MoreBoris Weiss, CEO of Medipure Pharmaceuticals recently talked to us about the numerous clinical trials his company has in development throughout the world, including studies in Canada, United States, India, and Croatia.
Read More90 plus years ago, the book Statistical Methods for Research Workers established the P< .05 concept as a gold standard. But is it really a good benchmark?
Read MoreCanadian pharmaceutical company, Prometic Life Sciences, announced the latest data from their lead candidate, PBI-4050, to treat idiopathic pulmonary fibrosis (IPF), presented at the American Thoracic Society (ATS) 2018 International Conference being held in San Diego, California.
Read MoreThe goal is to develop a clinical trial that will limit the number of questions that doctors, insurance companies, patients, caregivers, and regulatory agencies will have about the trial’s results.
Read MoreCanadian pharmaceutical company, Prometic Life Sciences Inc provided an update on their ongoing Phase 2 clinical trial involving the use of PBI-4500 to treat patients with Alström syndrome. Alström syndrome is a rare genetic condition due to mutations in the ALMS1 gene.
Read More